project id: TCGA-PAAD; case submitter id: TCGA-2J-AABR; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.31; rna integrity number: 7.5; age at index: 60; days to birth: -22131; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 22131; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 438.0; icd 10 code: C25.8; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of pancreas; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of pancreas; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 243; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-2J-AABR-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 65.0; percent stromal cells: 0.0; percent tumor cells: 35.0; percent tumor nuclei: 20.0;